Clinical Trial Update: Infliximab for the Treatment of Early Rheumatoid Arthritis [Phase 2]

View source ↗

Summary

The document is an update on a Phase 2 trial of infliximab for early rheumatoid arthritis. The study status is listed as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Remicade (infliximab)

Snippet

Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | Conditions: Rheumatoid Arthritis | Phase 2 | Status: COMPLETED